Arsenic trioxide (As 2 O 3 , arsenite) efficiently kills cells from various hematologic malignancies and has successfully been employed especially for the treatment of acute promyelocytic leukemia. There and in lymphoid cells, we demonstrated that As 2 O 3 induces cell death in a caspase-2-and -9-independent fashion. Here, we address a potential role of death receptor signaling through the FADD/caspase-8 death-inducing signaling complex in As 2 O 3 -induced cell death. In detail, we demonstrate that As 2 O 3 induces cell death independently of caspase-8 or FADD and cannot be blocked by disruption of CD95/Fas receptor ligand interaction. Unlike in death receptor ligation-induced apoptosis, As 2 O 3 -induced cell death was not blocked by the broad-spectrum caspase inhibitor z-VAD-fmk or the caspase-8-specific inhibitor z-IETDfmk. Nevertheless, As 2 O 3 -induced cell death occurred in a regulated manner and was abrogated upon Bcl-2 overexpression. In contrast, As 2 O 3 -induced cell demise was neither blocked by the caspase-9 inhibitor z-LEHD-fmk nor substantially inhibited through the expression of a dominant negative caspase-9 mutant. Altogether our data demonstrate that As 2 O 3 -induced cell death occurs independently of the extrinsic death receptor pathway of apoptosis. Cell death proceeds entirely via an intrinsic, Bcl-2-controlled mitochondrial pathway that does, however, not rely on caspase-9.
Introduction
Arsenic trioxide (As 2 O 3 ) has sucessfully been employed to treat patients with newly diagnosed and relapsed acute promyelocytic leukemia (APL) (Shen et al., 1997; Soignet et al., 1998; Niu et al., 1999) . Mechanisms of As 2 O 3 -induced cell death, however, have only recently started to unravel. Initially, the central mechanism initiating As 2 O 3 -induced cell death was presumed to be degradation and targeting of the promyelocytic leukemia gene product-retinoic acid receptor alpha (PML-RARa) fusion protein, which is typically expressed in APL cells. However, recent data demonstrated that PML-RARanegative cell lines and cells from PML knockout mice are sensitive to As 2 O 3 (Akao et al., 1998; Wang et al., 1998; Zhang et al., 1998; Zhu et al., 1999) , thus questioning the importance of PML in cell demise mediated by As 2 O 3 .
In general, cell death occurs either through necrosis or apoptosis. Apoptotic cell death is either mediated through death receptors, the mitochondrial or the endoplasmatic reticulum pathway. The mitochondrial or intrinsic death pathway is induced via growth-factor deprivation or chemotherapeutic drugs and results in the release of cytochrome c into the cytosol, which is either accompanied or followed by the loss of the mitochondrial transmembrane potential (DC m ). Subsequently, cytochrome c oligomerizes with apoptotic protease activating factor-1 (APAF-1) in a strictly adenosine 5 0 -triphosphate (ATP)-dependent manner. The resulting multimeric complex, termed the apoptosome, facilitates the recruitment and activation of caspase-9 which subsequently triggers effector caspases, for example, caspase-3 or caspase-7 . Such caspase activation is enhanced by the IAP-antagonists Smac/Diablo and Omi/HtrA2, which are also released from the mitochondria during apoptosis. In contrast, Bcl-2 and Bcl-x L , two antiapoptotic members of the Bcl-2 protein family, efficiently inhibit the mitochondrial or intrinsic pathway of apoptosis . The death receptor pathway of apoptosis, in turn, is initiated through the ligation of a death receptor, for example, CD95 (Fas, APO-1) and the successive assembly of the death-inducing signaling complex (DISC) (Peter and Krammer, 2003) . In case of CD95 or the TRAIL receptor, the DISC consists of the cytoplasmic region of the receptor, the adaptor protein Fas-associating protein with a death domain (FADD) and pro-caspase-8 (FLICE) or pro-caspase-10. DISC assembly mediates the activation of caspase-8, thereby triggering downstream effector caspases, such as cas-pase-3, resulting in DNA fragmentation (Kischkel et al., 1995 (Kischkel et al., , 2000 . We recently demonstrated that As 2 O 3 -mediated cell death functions in the absence of caspase-2 and caspase-9, but is efficiently blocked by Bcl-x L , thus demonstrating the importance of mitochondria for As 2 O 3 -induced cell demise (Scholz et al., 2005) . Intrinsic and extrinsic pathways of apoptosis are, however, connected through caspase-8-mediated processing and activation of the BH3-only protein Bid. Truncated Bid (tBid) facilitates actvation of Bak/Bax, proapoptotic members of the Bcl-2 family and has important implications for the sensitization of cancer cells to DNAdamaging anticancer therapies von Haefen et al., 2004; Rudner et al., 2005) . Recent data suggested a key role for caspase-8 in As 2 O 3 -mediated cell death (Kitamura et al., 2000) . Furthermore, the participation of the mitochondrial apoptosis pathway was implied in arsenic-induced cell demise (Akao et al., 1998; Wang et al., 1998; Larochette et al., 1999; Hossain et al., 2000; Perkins et al., 2000) . This is supported by our recent finding that As 2 O 3 induces a regulated form of necrosislike cell death through a Bcl-x L inhibitable pathway.
In the present study, we therefore investigated the functional role of the death receptor pathway of apoptosis in As 2 O 3 -induced cell death. We show that As 2 O 3 -induced cell death is accomplished in the absence of the initiator caspase-8 or the FADD adaptor molecule. Our findings establish that As 2 O 3 induces cell death in a CD95 death receptor, caspase-8 and FADD independent fashion.
Results

As 2 O 3 -induced cell death occurs via the mitochondrial pathway
Data from myeloid leukemia-or Burkitt-like lymphomaderived cell lines as well as from cell-free systems indicate an involvement of mitochondria in As 2 O 3 -induced cell death (Larochette et al., 1999; Perkins et al., 2000) . Here, we employ mutants of the acute lymphoblastic leukemia cell line Jurkat to address the issue of death receptor signaling in As 2 O 3 -induced cell death. To corroborate the role of mitochondria in As 2 O 3 -mediated cell demise in our current setting, we employed Jurkat cells overexpressing Bcl-2. These Jurkat Bcl-2 cells or mock-transfectants (mock) were cultured for 48 h in the presence or absence of plastic immobilized, agonistic anti-CD95 antibody APO-1 (IgG 3 , 1 mg/ml) (Dhein et al., 1992) . CD95/Fas ligation induced apoptosis in Jurkat mock-transfectants, while Jurkat cells overexpressing Bcl-2 were protected from CD95-mediated apoptosis (Figure 1 ). Thus, Jurkat cells are 'type II' cells that regulate death receptor-induced apoptosis through the intrinsic pathway (Scaffidi et al., 1998) , although this dichometry into type I and II cells depends on the strength of the death ligand signal (Rudner et al., 2005) . Next, Jurkat transfectants were cultured for 24 or 48 h with increasing concentrations of As 2 O 3 (Figure 2 ). Cell death was quantified by staining cells with annexin-V-FITC and propidium iodide (PI). Total cell death includes cells that are either annexin-V-FITC or PI positive (Figure 2a ). In contrast, positivity for annexin-V-FITC in the absence of PI staining (Figure 2b ) is characteristic for apoptosis, while positivity for PI (Figure 2c ), that is, membrane damage, indicates a necrotic type of cell death (Vermes et al., 1995) . In line with our previous report (Scholz et al., 2005) , As 2 O 3 induced a substantial amount necrosis-like death in mock-transfected Jurkat cells as evidenced by the large proportion of PI-positive cells (Figure 2c , open circles). Bcl-2 overexpression efficiently blocked apoptosis-and necrosis-like cell death in response to treatment with As 2 O 3 (Figure 2a -c, closed circles). Apart from assessing cell death by detecting annexin/PI, we measured cells with hypodiploid DNA, as an alternative method of quantifying apoptotic cells (Figure 2d ). Similar to the data shown in Figure 2b (Fischer et al., 2003) and initiate DNA fragmentation and cell death. Previous data from our group von Haefen et al., 2003) demonstrated that caspase-8 can furthermore be processed 'retrogradely' via caspase-3 and may thereby mediate a caspase-3/8-driven mitochondrial amplification loop (Fischer et al., 2003; von Haefen et al., 2003) . Although recent data indicate that caspase-8 processing is dispensable for caspase-8 activation, the role of caspase-8 activation outside of the DISC as executioner caspase in the intrinsic cell death pathway is under controversial discussion (Boatright et al., 2003; Chandra et al., 2004; Sohn et al., 2005) . Taking this into account, we next wanted to test whether caspase-8 activity was necessary for As 2 O 3 -mediated cell death. Accordingly, we utilized a caspase-8-deficient Jurkat cell line (caspase-8À/À). As anticipated, a 48 h culture of both cell lines with the plastic-bound, agonistic anti-CD95 antibody APO-1 (Dhein et al., 1992) (Figure 4c ), or cells with hypodiploid DNA (Figure 4d ). Caspase-8À/À Jurkat cells even appeared to be slightly more susceptible to apoptosis-like cell death as determined by measuring percentages of annexin-V-FITC single-positive cells (Figure 4b ). To assess whether As 2 O 3 mediates more pronounced apoptosis-like cell death at earlier time points, we exposed caspase-8 wild-type Jurkat A3 cells for 3, 6, and 12 h to As 2 O 3 . While cells remained largely unaffected after a 3 or 6 h treatment, there was a To further assess the functional role of caspase activation in As 2 O 3 -induced cell death, Jurkat A3 cells were treated for 48 h with either medium, the plasticbound anti-CD95 antibody (APO-1, 1 mg/ml), or As 2 O 3 (6 mM) in the presence or absence of the broad-spectrum caspase inhibitor z-VAD-fmk (10 mM) (Figure 6a ) or the caspase-8 inhibitor z-IETD-fmk (10 mM) (Figure 6b ). To this end, z-VAD-fmk (Figure 6a ) or z-IETD-fmk ( Figure 6b ) decreased anti-CD95-mediated cell death from 68.370.5 to 15.370.7 or to 38.970.6%, respectively. In contrast, As 2 O 3 -induced cell demise was only moderately reduced from 45.270.9 to 30.570.8% in the presence of z-VAD-fmk ( Figure 6a ) and not reduced in the presence of z-IETD-fmk ( Figure 6b ). This demonstrates that As 2 O 3 -induced cell death functions largely independent of caspase activity in general and of . As a control, cells were treated with the cytostatic drug taxol in the presence or absence of z-VAD-fmk. While taxol-induced cell death was substantially inhibited by either dosage of z-VAD-fmk, we only observed a moderate inhibition of As 2 O 3 -mediated cell death after a 24 h culture and hardly any decrease after a 48 h incubation with As 2 O 3 in the presence of 20 or 40 mM z-VAD-fmk ( Figure 7 ). Thus, a significant share of As 2 O 3 -triggered cell death proceeds via a caspase-independent mechanism as caspase-inhibition appears to only slightly diminish cell death of Jurkat cells. This is supported by our earlier data in caspase-2 and -9 knockout cells that remained sensitive upon exposure to As 2 O 3 (Scholz et al., 2005) . (Figure 9b ). To corroborate our data in a different system, we employed a cell line derived from a Burkitt-like lymphoma (BJAB) that had been transfected with a dominant negative mutant of FADD (FADD-DN). Again, BJAB FADD-DN or mock-transfected controls were treated with increasing concentrations of As 2 O 3 and cell death was measured by staining with annexin-V-FITC or PI after 24 and 48 h of culture. In line with our previous results, As 2 O 3 induced similar percentages of cell death in both cell lines (Figure 10) . Notably, total cell death was only moderately decreased in BJAB FADD-DN as compared to BJAB mock (Figure 10a ). Therefore, FADD appears to be largely dispensible for As 2 O 3 -induced cell demise.
As 2 O 3 -induced cell death cannot be inhibited through blockade of the death receptor CD95/Fas
Recent data demonstrated that a sublethal dosage of As 2 O 3 increases CD95/Fas expression on Hela cells, suggesting that As 2 O 3 might facilitate CD95-mediated cell death (Woo et al., 2004) . To address this and the To test this, Jurkat A3 cells were cultured with As 2 O 3 (6 mM) in the presence or absence of a soluble, anti-CD95 antibody (IgG 2b , clone SM1/23, 5 mg/ml), which was reported to block the induction of apoptosis mediated by anti-CD95 ligation (Klo¨pfer et al., 2004) . To validate the effect of the blocking anti-CD95 antibody (clone SM1/23) in our system, we cultured Jurkat A3 cells with plastic-bound, agonistic anti-CD95 antibody (clone 2R2, IgG 3 , 5 mg/ml) in the absence or presence of the soluble blocking antibody (clone SM1/23) for 48 h. Blocking the CD95/Fas receptor reduced total cell death induced by the agonistic anti-CD95 antibody from 37.971.1 to 8.470.9% (Figure 11 ). In contrast, total cell death induced by As 2 O 3 amounted to 65.171.7% in the absence compared to 69.073.5% in the presence of the soluble, blocking anti-CD95 antibody (clone SM1/23). Thus, apoptosis triggered through the ligation of the CD95/Fas receptor is not required for As 2 O 3 -mediated cell death.
As 2 O 3 induces substantial release of cytochrome c into the cytosol but mediates less pronounced activation of caspase-9
To corroborate the notion that As 2 O 3 facilitates cell death independent from caspases-8 and -9, that is, the initiator caspases in the extrinsic and the intrinsic apoptosis pathway, we treated Jurkat mock-or Bcl-2-transfected cells for 24 h with As 2 O 3 (4 mM) or epirubicin (2 mg/ml). Epirubicin has been shown to induce cell death through the mitochondrial pathway of apoptosis in a Bax-dependent manner (Hemmati et al., 2002) . In the mock-transfected Jurkat cells, epirubicin induced release of cytochrome c into the cytosol and processing of caspase-9 and -3, while no substantial Bid or caspase-8 cleavage were observed ( Figure 12 ). As expected, overexpression of Bcl-2 completey blocked cytochrome c release and caspase-9 cleavage in epirubicin-treated Jurkat Bcl-2 cells. Interestingly and in correspondence with recently published data from our group (Scholz et al., 2005) , treatment of Jurkat mock cells with As 2 O 3 induced a comparable amount of cytosolic cytochrome c but less pronounced caspase-9 cleavage (Figure 12 ). Similar to epirubicin-treated cells, no substantial Bid or caspase-8 cleavage was observed. Interestingly, cleavage of caspase-3 was more pronounced following treatment with As 2 O 3 as compared to epirubicin. It is of note, however, that treatment of Jurkat mock cells for 24 h with As 2 O 3 at 4 mM induced substantially more cell death than culture with epirubicin, that is, 52.5% as compared to 13.7% as epirubicin-induced cell death follows a far slower time course and reaches a maximum at 72 h (data not shown). As expected, Jurkat Bcl-2 cells demonstrated neither cytochrome c release nor caspase-9 or -3 processing upon culture with As 2 O 3 (4 mg/ml). Thus, As 2 O 3 induces a regulated, Bcl-2 inhibitable type of necrosis-like cell death which does not rely on caspase-8 or and involves only moderate caspase-9 activation. The contribution of caspase-3 in this setting remains to be established but should be marginal regarding the limited inhibition of cell death by zVAD-fmk.
As 2 O 3 mediates cell death regardless of caspase-9 inhibition
To further assess the role of caspase-9 during As 2 O 3 -induced cell death, we cultured Jurkat A3 cells with 4 mM As 2 O 3 in the absence or presence of 20 or 40 mM of the caspase-9-specific inhibitor z-LEHD-fmk. As a control, cells were treated with 0.01 mg/ml of the cytostatic agent paclitaxel (taxol). While we observed a moderate inhibition of taxol-induced cell death at 24 and 48 h, z-LEHD-fmk had no inhibitory effect on As 2 O 3 -mediated cell demise (Figure 13 ). Finally, we employed Jurkat cells transfected with a dominant negative caspase-9 mutant (caspase-9 DN) that interferes with activation of endogenous caspase-9 (Weinmann et al., 2004) . As a control, mock-transfected Jurkat cells transfected were employed. In line with the experiments employing the z-LEHD-fmk caspase-9 inhibitor, As 2 O 3 -induced cell death was only slightly reduced in Jurkat caspase-9 DN cells as compared to Jurkat mock cells (Figure 14) . Therefore, a functional caspase-9 does not seem to be a prerequisite of As 2 O 3 -induced cell death. Independence from caspase-9 is also supported by published data obtained in murine caspase-9 À/À fibro- blasts that were fully sensitive to As 2 O 3 -induced cell death (Scholz et al., 2005) .
Discussion
Owing to the impressive effects of As 2 O 3 in newly diagnosed and relapsed acute promyelocytic leukaemia (APL), mechanisms of As 2 O 3 -mediated cell death have recently come under increasing scrutiny. In the present report, we show that As 2 O 3 induces cell death independently of the death receptor pathway and the main constituents of the DISC, that is, CD95, caspase-8, and FADD. Corroborating this finding, As 2 O 3 -mediated cell death was only partially inhibited by the broad caspase inhibitor z-VAD-fmk and not at all by the caspase-8 inhibitor z-IETD-fmk. Likewise, blockade of the death receptor CD95 failed to reduce As 2 O 3 -induced cell demise. In line with this, As 2 O 3 -triggered cell death did not facilitate caspase-8-or Bid-cleavage. While the extrinsic death pathway appears dispensable for As 2 O 3 -triggered cell death, overexpression of Bcl-2, an antiapoptotic protein that inhibits mitochondrial damage and cytochrome c release in apoptosis, successfully prevented As 2 O 3 -induced cell death. In contrast, experiments with the caspase-9-specific inhibitor z-LEHD-fmk and with caspase-9 DN Jurkat cells demonstrated that a functional caspase-9 is not a prerequisite for As 2 O 3 -mediated cell death. Moreover, z-VAD-fmk only delayed induction of cell death by As 2 O 3 , indicating that caspases may contribute but are not decisive for As 2 O 3 -induced cell death. This is well in accordance with our findings in other systems showing independence from caspase-2 and -9. This emphasizes a key role for mitochondria during As 2 O 3 -mediated cell demise, but suggests that execution of cell death occurs through an apoptosome-independent pathway which does not require a functional caspase-9. As 2 O 3 has been used as a medicinal compound for centuries and has experienced a recent revival for the treatment of APL. The impressive effects on APL initially fostered the notion that As 2 O 3 -mediated cell death depends on the availability of the PML-RARa fusion protein, which is typical for APL. However, a number of recent publications have reported As 2 O 3 -mediated cell death in PML-RARa-and PML-negative cell lines (Akao et al., 1998; Wang et al., 1998; Zhang et al., 1998; Zhu et al., 1999) . Recent reports indicated that As 2 O 3 induces upregulation of the death receptor CD95/Fas and its ligand CD95L/FasL (Zhu et al., 2003; Woo et al., 2004) . Inhibition of the CD95/Fas death pathway with a blocking antibody to CD95/Fas was, furthermore, reported to decrease As 2 O 3 -induced cell death by 20-30% (Zhu et al., 2003) . This led the authors to suggest that the ligation of CD95 by CD95L plays a major role in As 2 O 3 -mediated cell death (Zhu et al., 2003) . This is in sharp contrast to our system where we performed a detailed study on the impact of DISC components in As 2 O 3 -induced cell death. Here, treatment of Jurkat A3 cells induced similar amounts of cell death in the absence or presence of a CD95-blocking antibody. When analysing components of the death receptor apoptosis pathway, we show that As 2 O 3 -induced cell death was largely unaffected in caspase-8À/À cells, was hardly blocked by the caspase-8-specific inhibitor z-IETD-fmk, and did not result in substantial caspase-8 cleavage as assessed by Western blot. Furthermore, As 2 O 3 -mediated cell death was largely undisturbed in FADD-deficient cells and cells trans- Figure 9 and 10, might be related to a putative role of FADD in the death-receptor-independent cleavage of initiator caspases such as caspase-8 (Chandra et al., 2004) . In line with this, we recently observed that FADD deficiency slightly reduces the amount of taxol-or fludarabine-induced cell death in a death-receptor-independent fashion von Haefen et al., 2003; Klo¨pfer et al., 2004) . Our data, therefore, demonstrate that neither CD95 ligation nor a functional FADD or caspase-8 is necessary for As 2 O 3 -induced cell death. These findings contradict data where caspase-8 was attributed with a central role during As 2 O 3 -induced cell death (Kitamura et al., 2000) . However, there, the authors solely reported the disappearance of a caspase-3 cleavage band and a partial reduction of the DC m decrease when adding the caspase-8-specific inhibitor z-IETD-fmk at 50 mM to cells treated with As 2 O 3 . Such high dosages of peptide inhibitors may affect other caspases and even other protease systems. Furthermore, neither loss of DC m nor caspase-3 cleavage is a specific consequence of caspase-8 activation. Thus, an essential role for caspase-8 in arsenicinduced cell demise was excluded in our systems and remains highly questionable in others. It was in fact intriguing to observe in our data that As 2 O 3 -induced cell death was only partially delayed by the broad-spectrum caspase inhibitor z-VAD-fmk, suggesting that As 2 O 3 -mediated cell death does not functionally depend on caspases. In line with this, the broad-spectrum caspase inhibitor z-VAD-fmk was shown to prevent As 2 O 3 -mediated nuclear fragmentation, a key sign of caspasedependent apoptosis, while failing to stop DC m reduction and loss of viability (Larochette et al., 1999) . This corroborates our finding that As 2 O 3 induces cell death in the absence of functional caspases. In accordance with this, we previously established that As 2 O 3 triggers cell death in the absence of caspase-2 and caspase-9 (Scholz et al., 2005) . This in turn coincides with our present data, where As 2 O 3 and the topoisomerase poison epirubicin induced similar amounts of cytosolic cytochrome c release but As 2 O 3 mediated a higher percentage of cell death along with a lower amount of cleaved caspased-9, as compared to epirubicin. Furthermore, neither inhibition of caspase-9 nor usage of caspase-9 DN mutants substantially blocked As 2 O 3 -mediated cell demise. To our notion, our results do not conflict with recently published data where As 2 O 3 was reported to massively induce apoptosis and to facilitate caspase-8, -9, and -3 processing (Liu et al., 2003) . Notably, the authors assessed cell death by staining cells with annexin-V-FITC only without counterstaining with PI. Thus, they failed to distinguish between cells with an apoptosis-and a necrosis-like phenotype and supposedly missed the often substantial proportion of necrotic, that is, annexin-V-FITC-negative, but nevertheless PI-positive cells. While our present data alongside with our previously reported results (Scholz et al., 2005) are compatible with the idea of a limited As 2 O 3 -mediated caspase activation, we emphasize that As 2 O 3 does not depend on functional initator caspases, that is, caspase-8, -2, or -9 for effective execution of cell death. In contrast, constitutive expression of Bcl-2 completely blocked As 2 O 3 -mediated cell death, mitochondrial permeability transition, and cytochrome c release. This is in line with data where constitutive expression of Bcl-2 in myelomonocytic cells inhibited As 2 O 3 -induced cell demise (Larochette et al., 1999) .
In conclusion, we show here that As 2 O 3 triggers a regulated, but predominantly necrotic mode of cell death that occurs independently of CD95 ligation, caspase-8, and FADD expression and does not require a functional caspase-9. The complete blockade of As 2 O 3 -mediated cell death in cells with constitutive overexpression of Bcl-2 corroborates the prominent role of the mitochondrial pathway during As 2 O 3 -induced cell death.
Materials and methods
Reagents
As 2 O 3 was purchased from Sigma-Aldrich (Taufkirchen, Germany). As 2 O 3 (1 mg) was dissolved in 1 ml 1 M sodium hydroxide (NaOH) solution to generate a 5 mM stock solution, which was serially diluted in RPMI 1640 supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 4 mM L-glutamine, and 10% fetal calf serum (GibcoBRL, Life Technologies, Karlsruhe, Germany), further depicted as complete medium.
Cell lines
Jurkat cells stably overexpressing Bcl-2 (Jurkat Bcl-2) and the corresponding mock-transfectants (Jurkat mock) have been described in detail before . The caspase-8À/À Jurkat cell line (Jurkat A3/C-8À/À) and the parental (Jurkat A3) line have been introduced elsewhere (Engels et al., 2000) . BJAB cells overexpressing a dominant-negative FADD mutant have been described recently (Klo¨pfer et al., 2004) . Jurkat cells deficient for FADD or the parental cell line (Jurkat A3) were kindly provided by J Blenis (Harvard Medical School, Boston, MA, USA) and have been characterized before (Klo¨pfer et al., 2004) . Jurkat cells transfected with a dominant negative mutant of caspase-9 (Jurkat caspase-9 DN) or the vector control cell line were provided by C Belka, University of Tu¨bingen Jendrossek et al., 2003a, b; Klo¨pfer et al., 2004; Weinmann et al., 2004; Rudner et al., 2005) . Prior to the experiments, cells were cultured overnight in complete medium, at a concentration of 4 Â 10 5 to allow logarithmic growth. Subsequently, cells were recounted, seeded at a denisty of 1 Â 10 5 cells/ml and cultured with medium alone, As 2 O 3 , agonistic anti-CD95/Fas antibody anti-APO-1 (Ig G3 ) (Dhein et al., 1992) , agonistic anti-APO-1/Fas clone 2R2 (Ig G3 ) (Bender MedSystems, Vienna, Austria), or the anti-CD95/Fas-blocking antibody anti-APO-1/Fas clone SM1/23 (IgG 2b ) (Bender MedSystems, Vienna, Austria), at concentrations and time periods as indicated. Where stated, the irreversible, broad caspase inhibitor z-VAD-fmk, the caspase-8 inhibitor z-IETD-fmk, or the caspase-9 inhibitor z-LEHD-fmk (Calbiochem, Bad Soden, Germany) were employed at the respective concentrations 1 h before the addition of cytotoxic agents. For longer incubation periods, the inhibitors were replenished every 24 h. The maximal concentration of DMSO present when the caspase inhibitor z-VAD-fmk, z-IETD-fmk, or z-LEHD-fmk was used had no effect on cell growth or cell death.
Measurement of cell death by assessing annexin-V-FITC and PI
Cell death was determined by staining cells with annexin-V-FITC and counterstaining with PI. Annexin-V-FITC binds to phosphatidylserine (PS) on the outer leaflet of the plasma membrane. PI is excluded by cells with intact membranes. PI positivity is therefore a sign of necrosis, whereas cells positive for annexin-V, but negative for PI are generally defined as apoptotic (Vermes et al., 1995) . Briefly, to determine apoptosis, cells were washed twice with cold PBS and resuspended in binding buffer (10 mM N-[2-hydroxyethyl]piperazin-N 0 -3[propansulfonicacid]/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) at a concentration of 1 Â 10 6 cells/ml. Next, 5 ml of annexin-V-FITC (BD PharMingen, Heidelberg, Germany) and 10 ml PI (20 mg/ml, Sigma-Aldrich) were added. Analyses were performed using a FACScan (Becton Dickinson, Heidelberg, Germany) and CellQuest analysis software.
Assessment of genomic DNA fragmentation by flow cytometric measurement of nuclear DNA content
To measure genomic DNA fragmentation, nuclear DNA content was determined by flow cytometry as described (Daniel et al., 1998) . Briefly, 10 5 cells were pelleted in a 96-well U-bottom plate. The pellet was then gently resuspended with 200 ml buffer (50 mg/ml PI, 0.1% sodium citrate, 0.1% Triton X-100) and incubated overnight in the dark at 41C. Genomic DNA content was determined using a FACScan flow cytometer (Becton Dickinson, Heidelberg, Germany) and CellQuest analysis software. Nuclei displaying a hypodiploid, sub-G1 DNA content were identified as apoptotic. Cell debris, characterized by low forward and side scatter values, was excluded from the analysis.
Immunoblotting
After treatment under the respective conditions, cells were washed twice with PBS and lysed in buffer containing 10 mM Tris/HCl pH 7.5, 300 mM NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5mM EDTA, 1 mM pepstatin, 1 mM leupeptin, and 0.1 mM phenylmethylsulfonyl fluoride. Protein concentration was determined using the bicinchoninic acid assay (Pierce, Rockford, IL, USA), and equal amounts of protein (usually 20 mg per lane) were separated by SDS-PAGE. Immunoblotting was performed as described . Membranes (Schleicher & Schuell, Dassel, Germany) were swollen in CAPS-buffer (10 mM 3-[cyclohexylamino]propane-1-sulfonic acid, pH 11, 10% MeOH), and blotting was performed at 1 mA/cm 2 for 1 h in a transblot SD cell (BioRad, Munich, Germany). The membrane was blocked for 1 h in PBST (PBS, 0.05% Tween-20) containing 3% nonfat dry milk and incubated with the primary antibody for 1 h. As primary antibodies, either mouse monoclonal anti-human Bcl-2 antibody (Novocastra, Newcastle, UK), mouse monoclonal anti-human-cytochrome c antibody (BD PharMingen, Heidelberg, Germany), goat polyclonal anti-human caspase-9 antibody (R&D Systems, Wiesbaden, Germany), goat polyclonal anti-human Bid antibody (Santa Cruz, Heidelberg, Germany), mouse monoclonal anti-human caspase-8 antibody (Cell Signaling Technology, Beverly, MA, USA), or polyclonal rabitt anti-human b-actin antibody (Sigma-Aldrich, Taufkirchen, Germany) were employed. After washing in PBST, the respective secondary goat-anti-mouse and rabbit-anti-goat antibodies conjugated to horseradish peroxidase (Southern Biotechnology Associates, Birmingham, AL, USA) were applied for 1 h. Finally, the membrane was washed in PBST, and protein bands were detected using the enhanced chemiluminescence system (Amersham Buchler, Braunschweig, Germany). To detect cytochrome c released from mitochondria into the cytosol, cells were pelleted by centrifugation at 300 g for 5 min and resuspended in lysis buffer containing 20 mM HEPES pH 7.4, 10 mM KCl, 2 mM MgCl 2 , 1mM EDTA, 100 mM DTT, 0.1 mM PMSF, and 0.75 mg/ml digitonin. Following incubation for 30 min on ice, cell lysates were centrifuged at 13 000 g at 41C for 15 min. Supernatants containing cytosolic protein were processed as described above.
Statistics
All experiments were performed at least three times. Results are expressed as means7standard deviation (s.d.).
